{"id":38573,"date":"2025-10-15T09:16:40","date_gmt":"2025-10-15T12:16:40","guid":{"rendered":"https:\/\/www.grupomedcof.com.br\/blog\/?p=38573"},"modified":"2025-10-15T09:55:06","modified_gmt":"2025-10-15T12:55:06","slug":"cancer-de-rim-e-bexiga","status":"publish","type":"post","link":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/","title":{"rendered":"C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_74 counter-hierarchy ez-toc-counter ez-toc-transparent ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Sum\u00e1rio<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabela de conte\u00fado\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#Carcinoma_de_Celulas_Renais_CCR\" >Carcinoma de C\u00e9lulas Renais (CCR)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#Epidemiologia\" >Epidemiologia<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#Qual_o_quadro_clinico_e_como_fazer_o_diagnostico\" >Qual o quadro cl\u00ednico e como fazer o diagn\u00f3stico?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#A_Classificacao_de_Bosniak_para_Lesoes_Cisticas\" >A Classifica\u00e7\u00e3o de Bosniak para Les\u00f5es C\u00edsticas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#Como_fazer_o_estadiamento_e_o_tratamento\" >Como fazer o estadiamento e o tratamento?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#Cancer_de_Bexiga_Carcinoma_Urotelial\" >C\u00e2ncer de Bexiga (Carcinoma Urotelial)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#Epidemiologia_e_Fatores_de_Risco\" >Epidemiologia e Fatores de Risco<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#Quadro_Clinico_e_Investigacao\" >Quadro Cl\u00ednico e Investiga\u00e7\u00e3o<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#Diagnostico_Estadiamento_e_Classificacao_de_Risco\" >Diagn\u00f3stico, Estadiamento e Classifica\u00e7\u00e3o de Risco<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#Tratamento\" >Tratamento<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#Conquiste_a_aprovacao_e_acompanhe_mais_noticias\" >Conquiste a aprova\u00e7\u00e3o e acompanhe mais not\u00edcias!<\/a><\/li><\/ul><\/nav><\/div>\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099-1024x576.jpg\" alt=\"\" class=\"wp-image-38583\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099-1024x576.jpg 1024w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099-300x169.jpg 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099-768x432.jpg 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099-1536x864.jpg 1536w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099-747x420.jpg 747w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099-150x84.jpg 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099-696x392.jpg 696w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099-1068x601.jpg 1068w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>A <strong>uro-oncologia<\/strong> \u00e9 um campo vasto e de extrema import\u00e2ncia na pr\u00e1tica m\u00e9dica. Por isso, precisamos nos aprofundar em dois dos t\u00f3picos mais relevantes: o <strong>Carcinoma de C\u00e9lulas Renais (CCR) e o C\u00e2ncer de Bexiga.<\/strong>&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-carcinoma-de-celulas-renais-ccr\"><span class=\"ez-toc-section\" id=\"Carcinoma_de_Celulas_Renais_CCR\"><\/span><strong>Carcinoma de C\u00e9lulas Renais (CCR)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>O <strong>c\u00e2ncer de rim<\/strong> \u00e9 a neoplasia urol\u00f3gica mais <strong>letal<\/strong>, principalmente porque seu diagn\u00f3stico costuma ocorrer em est\u00e1gios avan\u00e7ados.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-epidemiologia\"><span class=\"ez-toc-section\" id=\"Epidemiologia\"><\/span><strong>Epidemiologia<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>O CCR abrange um grupo de tumores com diferentes subtipos histol\u00f3gicos e progn\u00f3sticos.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Tipos Histol\u00f3gicos Principais:<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Tumor de C\u00e9lulas Claras (80%):<\/strong> \u00c9 o mais comum, geralmente se apresenta como uma massa circunscrita em exames de imagem e possui o pior progn\u00f3stico.<\/li>\n\n\n\n<li><strong>Carcinoma Papilar (10-15%):<\/strong> Frequentemente multic\u00eantrico e associado a pacientes com Doen\u00e7a Renal Cr\u00f4nica (DRC) terminal.<\/li>\n\n\n\n<li><strong>Tumor Crom\u00f3fobo (5%):<\/strong> Apresenta um bom progn\u00f3stico.<\/li>\n\n\n\n<li><strong>Carcinoma Medular Renal:<\/strong> Um tipo raro e extremamente agressivo que afeta jovens, com forte associa\u00e7\u00e3o \u00e0 anemia falciforme e mortalidade pr\u00f3xima de 100%.<\/li>\n\n\n\n<li><strong>Diferencia\u00e7\u00e3o Sarcomatoide:<\/strong> Um achado histopatol\u00f3gico presente em cerca de 5% dos CCRs que indica crescimento agressivo e met\u00e1stases precoces.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"423\" height=\"537\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-13.png\" alt=\"\" class=\"wp-image-38574\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-13.png 423w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-13-236x300.png 236w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-13-331x420.png 331w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-13-150x190.png 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-13-300x381.png 300w\" sizes=\"auto, (max-width: 423px) 100vw, 423px\" \/><figcaption class=\"wp-element-caption\">Tumor agressivo do Rim direito. Fonte: Reddan D et al. The American Journal of Medicine, 2001<\/figcaption><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Fatores de Risco:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Tabagismo.<\/li>\n\n\n\n<li>Hipertens\u00e3o Arterial Sist\u00eamica (HAS).<\/li>\n\n\n\n<li>Obesidade.<\/li>\n\n\n\n<li>Doen\u00e7a Renal Cr\u00f4nica (incluindo pacientes em di\u00e1lise).<\/li>\n\n\n\n<li>S\u00edndromes familiares (ex: Von Hippel-Lindau, Esclerose Tuberosa).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-qual-o-quadro-clinico-e-como-fazer-o-diagnostico\"><span class=\"ez-toc-section\" id=\"Qual_o_quadro_clinico_e_como_fazer_o_diagnostico\"><\/span><strong>Qual o quadro cl\u00ednico e como fazer o diagn\u00f3stico?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>At\u00e9 60% dos casos s\u00e3o diagnosticados incidentalmente durante exames de imagem para outras condi\u00e7\u00f5es. Quando presentes, os sintomas geralmente indicam doen\u00e7a avan\u00e7ada.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Tr\u00edade Cl\u00e1ssica (presente em &lt;30% dos casos):<\/strong>\n<ul class=\"wp-block-list\">\n<li>Dor lombar.<\/li>\n\n\n\n<li>Massa palp\u00e1vel.<\/li>\n\n\n\n<li>Hemat\u00faria.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>S\u00edndromes Paraneopl\u00e1sicas:<\/strong> HAS, anemia, febre de origem indeterminada e a <strong>S\u00edndrome de Stauffer<\/strong> (disfun\u00e7\u00e3o hep\u00e1tica n\u00e3o metast\u00e1tica) s\u00e3o achados poss\u00edveis.<\/li>\n\n\n\n<li><strong>Diagn\u00f3stico por Imagem:<\/strong>\n<ul class=\"wp-block-list\">\n<li>A <strong>Tomografia Computadorizada (TC) de abdome e pelve com contraste<\/strong> \u00e9 o padr\u00e3o-ouro para diagn\u00f3stico e estadiamento.<\/li>\n\n\n\n<li>A Resson\u00e2ncia Magn\u00e9tica (RM) \u00e9 uma alternativa importante em caso de alergia ao contraste iodado, para avaliar trombose venosa tumoral ou para diferenciar les\u00f5es c\u00edsticas complexas.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"609\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Imagem-de-tomografia-computadorizada-em-incidencia-transversal-mostrando-volumoso-tumor-renal-direito-arquivo-Dr.-Fernando-Zapparoli-1024x609-1.jpg\" alt=\"\" class=\"wp-image-38575\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Imagem-de-tomografia-computadorizada-em-incidencia-transversal-mostrando-volumoso-tumor-renal-direito-arquivo-Dr.-Fernando-Zapparoli-1024x609-1.jpg 1024w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Imagem-de-tomografia-computadorizada-em-incidencia-transversal-mostrando-volumoso-tumor-renal-direito-arquivo-Dr.-Fernando-Zapparoli-1024x609-1-300x178.jpg 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Imagem-de-tomografia-computadorizada-em-incidencia-transversal-mostrando-volumoso-tumor-renal-direito-arquivo-Dr.-Fernando-Zapparoli-1024x609-1-768x457.jpg 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Imagem-de-tomografia-computadorizada-em-incidencia-transversal-mostrando-volumoso-tumor-renal-direito-arquivo-Dr.-Fernando-Zapparoli-1024x609-1-706x420.jpg 706w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Imagem-de-tomografia-computadorizada-em-incidencia-transversal-mostrando-volumoso-tumor-renal-direito-arquivo-Dr.-Fernando-Zapparoli-1024x609-1-150x89.jpg 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Imagem-de-tomografia-computadorizada-em-incidencia-transversal-mostrando-volumoso-tumor-renal-direito-arquivo-Dr.-Fernando-Zapparoli-1024x609-1-696x414.jpg 696w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">Imagem de tomografia computadorizada em incid\u00eancia transversal, mostrando volumoso tumor renal direito (arquivo Dr. Fernando Zapparoli). Fonte:<a href=\"https:\/\/drfernandozapparoli.com.br\/cancer-de-rim\/\">https:\/\/drfernandozapparoli.com.br\/cancer-de-rim\/<\/a>&nbsp;<\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-a-classificacao-de-bosniak-para-lesoes-cisticas\"><span class=\"ez-toc-section\" id=\"A_Classificacao_de_Bosniak_para_Lesoes_Cisticas\"><\/span><strong>A Classifica\u00e7\u00e3o de Bosniak para Les\u00f5es C\u00edsticas<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>A classifica\u00e7\u00e3o de Bosniak \u00e9 fundamental para guiar a conduta em les\u00f5es c\u00edsticas renais encontradas na TC.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Bosniak 1 e 2:<\/strong> Cistos simples, considerados benignos (0% de malignidade), n\u00e3o necessitam de seguimento.<\/li>\n\n\n\n<li><strong>Bosniak 2F (&#8220;F&#8221; de <\/strong><strong><em>Follow-up<\/em><\/strong><strong>):<\/strong> Cistos com algumas septa\u00e7\u00f5es finas ou microcalcifica\u00e7\u00f5es. Possuem baixo risco de malignidade (cerca de 5%) e exigem acompanhamento com exames de imagem (geralmente TC em 6 meses).<\/li>\n\n\n\n<li><strong>Bosniak 3:<\/strong> Les\u00f5es com septos espessos ou realce pelo contraste. O risco de malignidade \u00e9 de aproximadamente 50%, e a recomenda\u00e7\u00e3o \u00e9 o tratamento cir\u00fargico.<\/li>\n\n\n\n<li><strong>Bosniak 4:<\/strong> Les\u00f5es c\u00edsticas com componentes s\u00f3lidos e realce pelo contraste. S\u00e3o consideradas 100% malignas at\u00e9 prova em contr\u00e1rio, indicando tratamento cir\u00fargico.<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"694\" height=\"512\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-14.png\" alt=\"Classifica\u00e7\u00e3o de Bosniak dos cistos renais, indicando porcentagem de malignidade: Bosniak 1 e 2 (0%), Bosniak 2F (5%), Bosniak 3 (50%) e Bosniak 4 (100%).\" class=\"wp-image-38576\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-14.png 694w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-14-300x221.png 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-14-569x420.png 569w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-14-80x60.png 80w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-14-150x111.png 150w\" sizes=\"auto, (max-width: 694px) 100vw, 694px\" \/><figcaption class=\"wp-element-caption\">Classifica\u00e7\u00e3o de Bosniak do CA de rim. | Acervo de aulas do Grupo MedCof.&nbsp;<\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-como-fazer-o-estadiamento-e-o-tratamento\"><span class=\"ez-toc-section\" id=\"Como_fazer_o_estadiamento_e_o_tratamento\"><\/span><strong>Como fazer o estadiamento e o tratamento?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>O tratamento do CCR \u00e9 eminentemente cir\u00fargico, visto que s\u00e3o <a href=\"https:\/\/www.grupomedcof.com.br\/blog\/oncologia\/\" target=\"_blank\" rel=\"noreferrer noopener\">tumores quimio e radiorresistentes.<\/a><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Estadiamento (TNM Simplificado):<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>T1:<\/strong> Tumor \u2264 7 cm, restrito ao rim.<\/li>\n\n\n\n<li><strong>T2:<\/strong> Tumor &gt; 7 cm, restrito ao rim.<\/li>\n\n\n\n<li><strong>T3:<\/strong> O tumor invade grandes veias ou o tecido perirrenal, mas n\u00e3o ultrapassa a f\u00e1scia de Gerota.<\/li>\n\n\n\n<li><strong>T4:<\/strong> O tumor invade al\u00e9m da f\u00e1scia de Gerota ou a gl\u00e2ndula adrenal ipsilateral.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Modalidades de Tratamento:<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Vigil\u00e2ncia Ativa ou Terapias Ablativas:<\/strong> Op\u00e7\u00f5es para tumores pequenos (&lt; 3 cm) em pacientes com comorbidades ou baixo <em>status performance<\/em>.<\/li>\n\n\n\n<li><strong>Nefrectomia Parcial:<\/strong> \u00c9 o tratamento padr\u00e3o para tumores T1, visando preservar a fun\u00e7\u00e3o renal.<\/li>\n\n\n\n<li><strong>Nefrectomia Radical:<\/strong> Indicada para tumores T2 ou maiores, ou quando a cirurgia parcial n\u00e3o \u00e9 tecnicamente vi\u00e1vel.<\/li>\n\n\n\n<li><strong>Cirurgia Citorredutora:<\/strong> Em pacientes com doen\u00e7a metast\u00e1tica, a remo\u00e7\u00e3o do tumor prim\u00e1rio pode aumentar a sobrevida, especialmente quando associada a terapia-alvo.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"428\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-15-1024x428.png\" alt=\"Etapas de cirurgia citoredutora renal mostrando remo\u00e7\u00e3o do tumor e sutura do rim ap\u00f3s ressec\u00e7\u00e3o.\" class=\"wp-image-38577\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-15-1024x428.png 1024w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-15-300x125.png 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-15-768x321.png 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-15-1004x420.png 1004w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-15-150x63.png 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-15-696x291.png 696w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-15-1068x447.png 1068w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-15.png 1241w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">Ilustra\u00e7\u00e3o de cirurgia citorredutora. | Acervo de Aulas do Grupo MedCof.<\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cancer-de-bexiga-carcinoma-urotelial\"><span class=\"ez-toc-section\" id=\"Cancer_de_Bexiga_Carcinoma_Urotelial\"><\/span><strong>C\u00e2ncer de Bexiga (Carcinoma Urotelial)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>O <strong>c\u00e2ncer de bexiga<\/strong> origina-se no <a href=\"https:\/\/www.grupomedcof.com.br\/blog\/urologia\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>urot\u00e9lio<\/strong>,<\/a> o epit\u00e9lio que reveste o trato urin\u00e1rio desde a pelve renal at\u00e9 a bexiga. A distin\u00e7\u00e3o fundamental para progn\u00f3stico e tratamento \u00e9 se o tumor invade ou n\u00e3o a camada muscular (m\u00fasculo detrusor).<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"480\" height=\"482\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-16.png\" alt=\"\" class=\"wp-image-38578\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-16.png 480w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-16-300x301.png 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-16-150x151.png 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-16-418x420.png 418w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-16-96x96.png 96w\" sizes=\"auto, (max-width: 480px) 100vw, 480px\" \/><figcaption class=\"wp-element-caption\">Exame citopatol\u00f3gico do c\u00e2ncer de bexiga. Fonte: https:\/\/medicine.nus.edu.sg\/pathweb\/normalhistology\/ bladder\/&nbsp;<\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-epidemiologia-e-fatores-de-risco\"><span class=\"ez-toc-section\" id=\"Epidemiologia_e_Fatores_de_Risco\"><\/span><strong>Epidemiologia e Fatores de Risco<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Tabagismo:<\/strong> \u00c9 o principal fator de risco.<\/li>\n\n\n\n<li><strong>Exposi\u00e7\u00e3o Ocupacional:<\/strong> Contato com aminas arom\u00e1ticas em ind\u00fastrias de corantes, borracha e petroqu\u00edmicas.<\/li>\n\n\n\n<li><strong>Radioterapia P\u00e9lvica:<\/strong> Tratamento pr\u00e9vio para outras neoplasias p\u00e9lvicas.<\/li>\n\n\n\n<li><strong>Esquistossomose:<\/strong> Relevante em algumas regi\u00f5es do mundo, como o Egito, mas n\u00e3o \u00e9 um fator t\u00edpico no Brasil.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-quadro-clinico-e-investigacao\"><span class=\"ez-toc-section\" id=\"Quadro_Clinico_e_Investigacao\"><\/span><strong>Quadro Cl\u00ednico e Investiga\u00e7\u00e3o<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hemat\u00faria:<\/strong> \u00c9 o sinal de alerta cardinal. Pode ser macrosc\u00f3pica (13% dos casos ter\u00e3o diagn\u00f3stico de c\u00e2ncer) ou microsc\u00f3pica (3%).<\/li>\n\n\n\n<li><strong>Sintomas Irritativos (LUTS):<\/strong> Dis\u00faria, polaci\u00faria e urg\u00eancia podem ocorrer.<\/li>\n\n\n\n<li><strong>Investiga\u00e7\u00e3o Diagn\u00f3stica:<\/strong>\n<ol class=\"wp-block-list\">\n<li><strong>Cistoscopia:<\/strong> Exame essencial para visualizar diretamente a bexiga e identificar les\u00f5es suspeitas.<\/li>\n\n\n\n<li><strong>Urotomografia (UroTC):<\/strong> Padr\u00e3o-ouro para avaliar todo o trato urin\u00e1rio. \u00c9 uma TC com contraste que inclui uma fase excretora tardia para delinear o urot\u00e9lio.<\/li>\n\n\n\n<li><strong>Citologia Onc\u00f3tica Urin\u00e1ria:<\/strong> Pode detectar c\u00e9lulas tumorais na urina, sendo \u00fatil na investiga\u00e7\u00e3o.<\/li>\n<\/ol>\n<\/li>\n<\/ul>\n\n\n\n<p>A abordagem da <strong>hemat\u00faria microsc\u00f3pica<\/strong> \u00e9 estratificada por risco (baixo, intermedi\u00e1rio, alto) com base na idade, hist\u00f3rico de tabagismo e grau de hemat\u00faria, definindo a necessidade de investiga\u00e7\u00e3o mais ou menos invasiva.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"842\" height=\"316\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-17.png\" alt=\"Tabela de estratifica\u00e7\u00e3o de risco para hemat\u00faria microsc\u00f3pica com categorias: baixo, intermedi\u00e1rio e alto risco, conforme tabagismo, idade e n\u00famero de hem\u00e1cias.\" class=\"wp-image-38579\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-17.png 842w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-17-300x113.png 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-17-768x288.png 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-17-150x56.png 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-17-696x261.png 696w\" sizes=\"auto, (max-width: 842px) 100vw, 842px\" \/><figcaption class=\"wp-element-caption\">Hemat\u00faria microsc\u00f3pica (estratifica\u00e7\u00e3o e conduta). | Acervo de aulas do Grupo MedCof.<\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-diagnostico-estadiamento-e-classificacao-de-risco\"><span class=\"ez-toc-section\" id=\"Diagnostico_Estadiamento_e_Classificacao_de_Risco\"><\/span><strong>Diagn\u00f3stico, Estadiamento e Classifica\u00e7\u00e3o de Risco<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>O diagn\u00f3stico definitivo e o estadiamento s\u00e3o realizados atrav\u00e9s da <strong>Ressec\u00e7\u00e3o Transuretral da Bexiga (RTU-B)<\/strong>.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Procedimento (RTU-B):<\/strong> Uma al\u00e7a de ressec\u00e7\u00e3o \u00e9 introduzida pela uretra para remover a les\u00e3o vis\u00edvel. \u00c9 crucial que a amostra contenha a camada muscular para determinar se o tumor \u00e9 m\u00fasculo-invasivo.<\/li>\n\n\n\n<li><strong>Re-RTU (Segunda Ressec\u00e7\u00e3o):<\/strong> Um novo procedimento realizado de 2 a 6 semanas ap\u00f3s a RTU inicial \u00e9 obrigat\u00f3rio em tumores T1, de alto grau (G3), m\u00faltiplos ou quando n\u00e3o h\u00e1 m\u00fasculo na primeira amostra, para garantir a remo\u00e7\u00e3o de tumor residual e confirmar o estadiamento.<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"817\" height=\"473\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-18.png\" alt=\"Procedimento endosc\u00f3pico com ressectosc\u00f3pio e al\u00e7a de 24-Fr para bi\u00f3psia da bexiga em diagn\u00f3stico anatomopatol\u00f3gico.\" class=\"wp-image-38580\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-18.png 817w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-18-300x174.png 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-18-768x445.png 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-18-725x420.png 725w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-18-150x87.png 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-18-696x403.png 696w\" sizes=\"auto, (max-width: 817px) 100vw, 817px\" \/><figcaption class=\"wp-element-caption\">Diagn\u00f3stico que se completa com o anatomopatol\u00f3gico. | Acervo de aula do Grupo MedCof.&nbsp;<\/figcaption><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>tadiamento (TNM Simplificado):<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Ta:<\/strong> Tumor papil\u00edfero n\u00e3o invasivo, confinado ao urot\u00e9lio.<\/li>\n\n\n\n<li><strong>Tis (Carcinoma in situ):<\/strong> Les\u00e3o plana, de alto grau, confinada ao epit\u00e9lio.<\/li>\n\n\n\n<li><strong>T1:<\/strong> O tumor invade o tecido conjuntivo subepitelial.<\/li>\n\n\n\n<li><strong>T2:<\/strong> O tumor invade a camada muscular.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Classifica\u00e7\u00e3o de Risco (Tumores N\u00e3o M\u00fasculo-Invasivos):<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Baixo Risco:<\/strong> Tumor \u00fanico, Ta, baixo grau, &lt; 3 cm, sem Tis.<\/li>\n\n\n\n<li><strong>Alto Risco:<\/strong> Tumor T1, alto grau, presen\u00e7a de Tis, ou tumores m\u00faltiplos e &gt; 3 cm.<\/li>\n\n\n\n<li><strong>Risco Intermedi\u00e1rio:<\/strong> Casos que n\u00e3o se enquadram nos crit\u00e9rios de baixo ou alto risco.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"841\" height=\"521\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-19.png\" alt=\"Compara\u00e7\u00e3o microsc\u00f3pica dos graus de desorganiza\u00e7\u00e3o celular em c\u00e2ncer de bexiga: baixo grau (G1), alto grau (G3) e carcinoma in situ (CIS).\" class=\"wp-image-38581\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-19.png 841w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-19-300x186.png 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-19-768x476.png 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-19-678x420.png 678w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-19-150x93.png 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-19-696x431.png 696w\" sizes=\"auto, (max-width: 841px) 100vw, 841px\" \/><figcaption class=\"wp-element-caption\">Grau de desorganiza\u00e7\u00e3o celular. | Acervo de aulas do Grupo MedCof.&nbsp;<\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-tratamento\"><span class=\"ez-toc-section\" id=\"Tratamento\"><\/span><strong>Tratamento<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>A abordagem terap\u00eautica depende fundamentalmente da invas\u00e3o da camada muscular.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Tumor N\u00e3o M\u00fasculo-Invasivo (Ta, T1, Tis):<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Baixo risco:<\/strong> RTU seguida de vigil\u00e2ncia com cistoscopia. Uma dose \u00fanica de quimioterapia intravesical pode ser considerada.<\/li>\n\n\n\n<li><strong>Risco Intermedi\u00e1rio\/Alto:<\/strong> Ap\u00f3s a RTU, o tratamento padr\u00e3o \u00e9 a imunoterapia intravesical com <strong>BCG<\/strong> (Bacilo de Calmette-Gu\u00e9rin), administrada por 1 a 3 anos para reduzir o risco de recorr\u00eancia e progress\u00e3o.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Tumor M\u00fasculo-Invasivo (\u2265T2):<\/strong>\n<ul class=\"wp-block-list\">\n<li>O tratamento padr\u00e3o \u00e9 a <strong>cistectomia radical<\/strong>.\n<ul class=\"wp-block-list\">\n<li><strong>Homens:<\/strong> Cistoprostatectomia (retirada da bexiga e pr\u00f3stata).<\/li>\n\n\n\n<li><strong>Mulheres:<\/strong> Exentera\u00e7\u00e3o p\u00e9lvica anterior (retirada da bexiga, \u00fatero e ov\u00e1rios).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>Ap\u00f3s a cistectomia, \u00e9 necess\u00e1ria uma <strong>deriva\u00e7\u00e3o urin\u00e1ria<\/strong>:\n<ul class=\"wp-block-list\">\n<li><strong>Conduto Ileal (Bricker):<\/strong> Um segmento do \u00edleo \u00e9 usado para criar um conduto que leva a urina dos ureteres para um estoma na parede abdominal (deriva\u00e7\u00e3o incontinente).<\/li>\n\n\n\n<li><strong>Neobexiga Ortot\u00f3pica:<\/strong> Um reservat\u00f3rio \u00e9 constru\u00eddo com o intestino e posicionado no local da bexiga original, permitindo ao paciente urinar pela uretra (deriva\u00e7\u00e3o continente).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"433\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-20-1024x433.png\" alt=\"Ilustra\u00e7\u00e3o m\u00e9dica do conduto ileal tipo Bricker mostrando a retirada de segmento intestinal e sua conex\u00e3o com ureteres para deriva\u00e7\u00e3o urin\u00e1ria.\" class=\"wp-image-38582\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-20-1024x433.png 1024w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-20-300x127.png 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-20-768x325.png 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-20-992x420.png 992w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-20-150x63.png 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-20-696x295.png 696w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-20-1068x452.png 1068w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/image-20.png 1160w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">Conduto ileal \u201cBricker\u201d. | Acervo de aulas do Grupo MedCof.&nbsp;<\/figcaption><\/figure>\n\n\n\n<p>O c\u00e2ncer de bexiga tem uma alta taxa de recidiva, exigindo seguimento rigoroso e cont\u00ednuo com cistoscopias peri\u00f3dicas, pois todo o urot\u00e9lio permanece em risco.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/aulas.grupomedcof.com.br\/atualizacoes-medicas-que-podem-definir-sua-aprovacao\" target=\"_blank\" rel=\" noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"214\" src=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-1024x214.jpeg\" alt=\"\" class=\"wp-image-38248\" srcset=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-1024x214.jpeg 1024w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-300x63.jpeg 300w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-768x161.jpeg 768w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-1536x321.jpeg 1536w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-2048x428.jpeg 2048w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-2009x420.jpeg 2009w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-150x31.jpeg 150w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-696x146.jpeg 696w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-1068x223.jpeg 1068w, https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/09\/banner-blog-1-1920x401.jpeg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-conquiste-a-aprovacao-e-acompanhe-mais-noticias\"><span class=\"ez-toc-section\" id=\"Conquiste_a_aprovacao_e_acompanhe_mais_noticias\"><\/span><strong>Conquiste a aprova\u00e7\u00e3o e acompanhe mais not\u00edcias!<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Gostou da novidade? Continue acompanhando nosso blog para ficar por dentro das principais&nbsp;<strong>not\u00edcias sobre resid\u00eancia m\u00e9dica, editais e oportunidades que podem transformar sua carreira!<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<div class=\"youtube-embed\" data-video_id=\"FG6WmoOeJcE\"><iframe loading=\"lazy\" title=\"Entendendo a Uro-Oncologia: Tudo sobre C\u00e2ncer de Bexiga. Com Dr. Afonso Bento\" width=\"696\" height=\"392\" src=\"https:\/\/www.youtube.com\/embed\/FG6WmoOeJcE?feature=oembed&#038;enablejsapi=1\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Conhe\u00e7a as principais caracter\u00edsticas, fatores de risco, sintomas, diagn\u00f3stico e tratamentos do c\u00e2ncer de rim e de bexiga.<\/p>\n","protected":false},"author":21,"featured_media":38583,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[74,206],"tags":[3250,3249,3251,3247],"ppma_author":[3617],"class_list":{"0":"post-38573","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-oncologia","8":"category-urologia","9":"tag-cancer-de-bexiga","10":"tag-cancer-de-rim","11":"tag-classificacao-de-bosniak","12":"tag-uro-oncologia"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.3 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento - Blog de Medcof: conte\u00fados, editais, revalida e mais!<\/title>\n<meta name=\"description\" content=\"Conhe\u00e7a as principais caracter\u00edsticas, fatores de risco, sintomas, diagn\u00f3stico e tratamentos do c\u00e2ncer de rim e de bexiga.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento\" \/>\n<meta property=\"og:description\" content=\"Conhe\u00e7a as principais caracter\u00edsticas, fatores de risco, sintomas, diagn\u00f3stico e tratamentos do c\u00e2ncer de rim e de bexiga.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog de Medcof: conte\u00fados, editais, revalida e mais!\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MedCofQbank\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-15T12:16:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-15T12:55:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kiara Adelino\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kiara Adelino\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/\"},\"author\":{\"name\":\"Kiara Adelino\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#\\\/schema\\\/person\\\/db19a651f86c5fc202d6eee744fd3292\"},\"headline\":\"C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento\",\"datePublished\":\"2025-10-15T12:16:40+00:00\",\"dateModified\":\"2025-10-15T12:55:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/\"},\"wordCount\":1476,\"publisher\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Blog-MedCof-2025-10-15T085203.099.jpg\",\"keywords\":[\"C\u00e2ncer de bexiga\",\"C\u00e2ncer de rim\",\"Classifica\u00e7\u00e3o de Bosniak\",\"Uro-Oncologia\"],\"articleSection\":[\"Oncologia\",\"Urologia\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/\",\"name\":\"C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento - Blog de Medcof: conte\u00fados, editais, revalida e mais!\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Blog-MedCof-2025-10-15T085203.099.jpg\",\"datePublished\":\"2025-10-15T12:16:40+00:00\",\"dateModified\":\"2025-10-15T12:55:06+00:00\",\"description\":\"Conhe\u00e7a as principais caracter\u00edsticas, fatores de risco, sintomas, diagn\u00f3stico e tratamentos do c\u00e2ncer de rim e de bexiga.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Blog-MedCof-2025-10-15T085203.099.jpg\",\"contentUrl\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Blog-MedCof-2025-10-15T085203.099.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/cancer-de-rim-e-bexiga\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/\",\"name\":\"Blog de Medcof: conte\u00fados, editais, revalida e mais!\",\"description\":\"Acesso o blog de MedCof! Seu portal de conte\u00fados sobre resid\u00eancia m\u00e9dica, an\u00e1lise e editais e muito mais. Clique e confira!\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#organization\"},\"alternateName\":\"Blog de Medcof: conte\u00fados, editais, revalida e mais!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#organization\",\"name\":\"Grupo MedCof\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/logo-medcof.png\",\"contentUrl\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/logo-medcof.png\",\"width\":768,\"height\":269,\"caption\":\"Grupo MedCof\"},\"image\":{\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/MedCofQbank\\\/\",\"https:\\\/\\\/www.instagram.com\\\/grupomedcof\\\/\",\"https:\\\/\\\/br.linkedin.com\\\/company\\\/medcof\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCdHMuOHKICxcHwecxN8P-AA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/#\\\/schema\\\/person\\\/db19a651f86c5fc202d6eee744fd3292\",\"name\":\"Kiara Adelino\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/cropped-Kiara-Adelino2-96x96.jpega85663bdda67261f8f06f86e555e1e49\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/cropped-Kiara-Adelino2-96x96.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/cropped-Kiara-Adelino2-96x96.jpeg\",\"caption\":\"Kiara Adelino\"},\"description\":\"Estudante do 5\u00b0 semestre de Medicina. Gosto bastante de aprender coisas novas, principalmente na \u00e1rea de Neurologia e Anatomia humana.\",\"url\":\"https:\\\/\\\/www.grupomedcof.com.br\\\/blog\\\/author\\\/kiara-adelino\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento - Blog de Medcof: conte\u00fados, editais, revalida e mais!","description":"Conhe\u00e7a as principais caracter\u00edsticas, fatores de risco, sintomas, diagn\u00f3stico e tratamentos do c\u00e2ncer de rim e de bexiga.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/","og_locale":"pt_BR","og_type":"article","og_title":"C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento","og_description":"Conhe\u00e7a as principais caracter\u00edsticas, fatores de risco, sintomas, diagn\u00f3stico e tratamentos do c\u00e2ncer de rim e de bexiga.","og_url":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/","og_site_name":"Blog de Medcof: conte\u00fados, editais, revalida e mais!","article_publisher":"https:\/\/www.facebook.com\/MedCofQbank\/","article_published_time":"2025-10-15T12:16:40+00:00","article_modified_time":"2025-10-15T12:55:06+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099.jpg","type":"image\/jpeg"}],"author":"Kiara Adelino","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Kiara Adelino","Est. tempo de leitura":"10 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#article","isPartOf":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/"},"author":{"name":"Kiara Adelino","@id":"https:\/\/www.grupomedcof.com.br\/blog\/#\/schema\/person\/db19a651f86c5fc202d6eee744fd3292"},"headline":"C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento","datePublished":"2025-10-15T12:16:40+00:00","dateModified":"2025-10-15T12:55:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/"},"wordCount":1476,"publisher":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/#organization"},"image":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#primaryimage"},"thumbnailUrl":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099.jpg","keywords":["C\u00e2ncer de bexiga","C\u00e2ncer de rim","Classifica\u00e7\u00e3o de Bosniak","Uro-Oncologia"],"articleSection":["Oncologia","Urologia"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/","url":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/","name":"C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento - Blog de Medcof: conte\u00fados, editais, revalida e mais!","isPartOf":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#primaryimage"},"image":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#primaryimage"},"thumbnailUrl":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099.jpg","datePublished":"2025-10-15T12:16:40+00:00","dateModified":"2025-10-15T12:55:06+00:00","description":"Conhe\u00e7a as principais caracter\u00edsticas, fatores de risco, sintomas, diagn\u00f3stico e tratamentos do c\u00e2ncer de rim e de bexiga.","breadcrumb":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#primaryimage","url":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099.jpg","contentUrl":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2025\/10\/Blog-MedCof-2025-10-15T085203.099.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.grupomedcof.com.br\/blog\/cancer-de-rim-e-bexiga\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.grupomedcof.com.br\/blog\/"},{"@type":"ListItem","position":2,"name":"C\u00e2nceres de rim e bexiga: entenda os principais tipos, sintomas e tratamento"}]},{"@type":"WebSite","@id":"https:\/\/www.grupomedcof.com.br\/blog\/#website","url":"https:\/\/www.grupomedcof.com.br\/blog\/","name":"Blog de Medcof: conte\u00fados, editais, revalida e mais!","description":"Acesso o blog de MedCof! Seu portal de conte\u00fados sobre resid\u00eancia m\u00e9dica, an\u00e1lise e editais e muito mais. Clique e confira!","publisher":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/#organization"},"alternateName":"Blog de Medcof: conte\u00fados, editais, revalida e mais!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.grupomedcof.com.br\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.grupomedcof.com.br\/blog\/#organization","name":"Grupo MedCof","url":"https:\/\/www.grupomedcof.com.br\/blog\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.grupomedcof.com.br\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2022\/01\/logo-medcof.png","contentUrl":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2022\/01\/logo-medcof.png","width":768,"height":269,"caption":"Grupo MedCof"},"image":{"@id":"https:\/\/www.grupomedcof.com.br\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MedCofQbank\/","https:\/\/www.instagram.com\/grupomedcof\/","https:\/\/br.linkedin.com\/company\/medcof","https:\/\/www.youtube.com\/channel\/UCdHMuOHKICxcHwecxN8P-AA"]},{"@type":"Person","@id":"https:\/\/www.grupomedcof.com.br\/blog\/#\/schema\/person\/db19a651f86c5fc202d6eee744fd3292","name":"Kiara Adelino","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2024\/08\/cropped-Kiara-Adelino2-96x96.jpega85663bdda67261f8f06f86e555e1e49","url":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2024\/08\/cropped-Kiara-Adelino2-96x96.jpeg","contentUrl":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2024\/08\/cropped-Kiara-Adelino2-96x96.jpeg","caption":"Kiara Adelino"},"description":"Estudante do 5\u00b0 semestre de Medicina. Gosto bastante de aprender coisas novas, principalmente na \u00e1rea de Neurologia e Anatomia humana.","url":"https:\/\/www.grupomedcof.com.br\/blog\/author\/kiara-adelino\/"}]}},"authors":[{"term_id":3617,"user_id":21,"is_guest":0,"slug":"kiara-adelino","display_name":"Kiara Adelino","avatar_url":"https:\/\/www.grupomedcof.com.br\/blog\/wp-content\/uploads\/2024\/08\/cropped-Kiara-Adelino2-96x96.jpeg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/posts\/38573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/comments?post=38573"}],"version-history":[{"count":2,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/posts\/38573\/revisions"}],"predecessor-version":[{"id":38594,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/posts\/38573\/revisions\/38594"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/media\/38583"}],"wp:attachment":[{"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/media?parent=38573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/categories?post=38573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/tags?post=38573"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.grupomedcof.com.br\/blog\/wp-json\/wp\/v2\/ppma_author?post=38573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}